News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,754 Results
Type
Article (41717)
Company Profile (267)
Press Release (683760)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (205457)
Career Advice (2030)
Deals (35688)
Drug Delivery (113)
Drug Development (81672)
Employer Resources (173)
FDA (16561)
Job Trends (14987)
News (347941)
Policy (33030)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2590)
Accelerated approval (34)
Adcomms (24)
Allergies (147)
Alliances (49980)
ALS (172)
Alzheimer's disease (1689)
Antibody-drug conjugate (ADC) (318)
Approvals (16835)
Artificial intelligence (522)
Autoimmune disease (161)
Automation (44)
Bankruptcy (361)
Best Places to Work (11656)
BIOSECURE Act (20)
Biosimilars (195)
Biotechnology (174)
Bladder cancer (161)
Brain cancer (57)
Breast cancer (649)
Cancer (4893)
Cardiovascular disease (411)
Career advice (1715)
Career pathing (36)
CAR-T (287)
CDC (47)
Celiac Disease (2)
Cell therapy (758)
Cervical cancer (37)
Clinical research (69862)
Collaboration (1733)
Company closure (4)
Compensation (1180)
Complete response letters (58)
COVID-19 (2730)
CRISPR (93)
C-suite (868)
Cystic fibrosis (143)
Data (6342)
Decentralized trials (2)
Denatured (25)
Depression (135)
Diabetes (505)
Diagnostics (6723)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (258)
Drug pricing (185)
Drug shortages (28)
Duchenne muscular dystrophy (234)
Earnings (90392)
Editorial (59)
Employer branding (21)
Employer resources (152)
Events (117782)
Executive appointments (986)
FDA (19736)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1484)
Gene editing (200)
Generative AI (44)
Gene therapy (600)
GLP-1 (972)
Government (4727)
Grass and pollen (7)
Guidances (384)
Healthcare (18962)
HIV (63)
Huntington's disease (45)
IgA nephropathy (84)
Immunology and inflammation (257)
Immuno-oncology (62)
Indications (121)
Infectious disease (3010)
Inflammatory bowel disease (197)
Inflation Reduction Act (14)
Influenza (121)
Intellectual property (256)
Interviews (317)
IPO (16658)
IRA (50)
Job creations (3664)
Job search strategy (1432)
JPM (57)
Kidney cancer (17)
Labor market (86)
Layoffs (554)
Leadership (32)
Legal (8012)
Liver cancer (91)
Longevity (15)
Lung cancer (661)
Lymphoma (383)
Machine learning (42)
Management (59)
Manufacturing (820)
MASH (165)
Medical device (13819)
Medtech (13877)
Mergers & acquisitions (20114)
Metabolic disorders (1280)
Multiple sclerosis (165)
NASH (16)
Neurodegenerative disease (327)
Neuropsychiatric disorders (89)
Neuroscience (2947)
Neurotech (1)
NextGen: Class of 2026 (6531)
Non-profit (4530)
Now hiring (68)
Obesity (600)
Opinion (266)
Ovarian cancer (167)
Pain (201)
Pancreatic cancer (232)
Parkinson's disease (285)
Partnered (33)
Patents (515)
Patient recruitment (499)
Peanut (58)
People (59136)
Pharmaceutical (62)
Pharmacy benefit managers (30)
Phase 1 (21758)
Phase 2 (30724)
Phase 3 (22940)
Pipeline (5519)
Policy (291)
Postmarket research (2582)
Preclinical (9232)
Press Release (65)
Prostate cancer (244)
Psychedelics (48)
Radiopharmaceuticals (285)
Rare diseases (861)
Real estate (6003)
Recruiting (70)
Regulatory (24773)
Reports (53)
Research institute (2399)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (81)
Schizophrenia (151)
Series A (240)
Series B (191)
Service/supplier (12)
Sickle cell disease (98)
Special edition (22)
Spinal muscular atrophy (160)
Sponsored (42)
Startups (3625)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (86)
The Weekly (55)
Vaccines (1019)
Venture capital (89)
Weight loss (385)
Women's health (96)
Worklife (18)
Date
Today (179)
Last 7 days (723)
Last 30 days (2428)
Last 365 days (29982)
2026 (4209)
2025 (30247)
2024 (35299)
2023 (40161)
2022 (51273)
2021 (55830)
2020 (54214)
2019 (46680)
2018 (35146)
2017 (32259)
2016 (31697)
2015 (37736)
2014 (31486)
2013 (26552)
2012 (28760)
2011 (29466)
2010 (27487)
Location
Africa (742)
Alabama (85)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (40511)
Australia (6469)
California (11465)
Canada (3325)
China (1112)
Colorado (482)
Connecticut (484)
Delaware (341)
Europe (85541)
Florida (1722)
Georgia (363)
Hawaii (3)
Idaho (61)
Illinois (875)
India (72)
Indiana (530)
Iowa (22)
Japan (454)
Kansas (127)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1419)
Massachusetts (8192)
Michigan (328)
Minnesota (631)
Mississippi (5)
Missouri (129)
Montana (32)
Nebraska (28)
Nevada (124)
New Hampshire (79)
New Jersey (3041)
New Mexico (28)
New York (3016)
North Carolina (1470)
North Dakota (8)
Northern California (5615)
Ohio (340)
Oklahoma (21)
Oregon (41)
Pennsylvania (2308)
Puerto Rico (24)
Rhode Island (48)
South America (1116)
South Carolina (68)
South Dakota (1)
Southern California (4471)
Tennessee (178)
Texas (1767)
United States (40611)
Utah (342)
Vermont (1)
Virginia (265)
Washington D.C. (81)
Washington State (930)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
725,754 Results for "japan tobacco inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PL BioScience Wins Regulatory Certification from Japan’s PMDA
February 11, 2026
·
3 min read
Press Releases
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
·
3 min read
Press Releases
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
December 23, 2025
·
7 min read
Press Releases
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma
December 23, 2025
·
7 min read
Press Releases
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan
February 2, 2026
·
7 min read
Press Releases
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
February 9, 2026
·
5 min read
Press Releases
Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for ‘CART BP pro’ in Japan
February 6, 2026
·
4 min read
Press Releases
Galderma Expands Restylane® Portfolio in Japan With Launch of OBT™ Hyaluronic Acid Injectables Restylane Defyne™ and Refyne™
February 11, 2026
·
7 min read
Press Releases
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region
October 16, 2025
·
12 min read
Press Releases
Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan
December 23, 2025
·
2 min read
1 of 72,576
Next
